NeoGenomics moves to Nasdaq


  • By
  • | 3:39 p.m. December 12, 2012
  • Charlotte–Lee–Collier
  • Share

FORT MYERS — The shares of cancer-testing firm NeoGenomics recently started trading on the Nasdaq Capital Market, boosting its exposure to institutional investors.

 

Continue reading your article
with a Business Observer subscription.
What's included:
  • ✓ Unlimited digital access to BusinessObserverFL.com
  • ✓ E-Newspaper app, digital replica of print edition
  • ✓ Mailed print newspaper every Friday (optional)
  • ✓ Newsletter of daily business news

Latest News

Sponsored Content